We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
4uy1
From Proteopedia
(Difference between revisions)
| Line 19: | Line 19: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: Bodin, C | + | [[Category: Bodin, C]] |
| - | [[Category: Chen, H | + | [[Category: Chen, H]] |
| - | [[Category: Hallberg, K | + | [[Category: Hallberg, K]] |
| - | [[Category: Oster, L | + | [[Category: Oster, L]] |
| - | [[Category: Sandmark, J | + | [[Category: Sandmark, J]] |
[[Category: Drug discovery]] | [[Category: Drug discovery]] | ||
[[Category: Fragment based lead generation]] | [[Category: Fragment based lead generation]] | ||
[[Category: Hydrolase]] | [[Category: Hydrolase]] | ||
[[Category: Virtual screening]] | [[Category: Virtual screening]] | ||
Revision as of 09:42, 17 December 2014
Novel pyrazole series of group X Secretory Phospholipase A2 (sPLA2-X) inhibitors
| |||||||||||
